This article presents the results of a survey conducted to gain insight on the impact of the COVID-19 pandemic on biomanufacturing operations.
Anthony J. Sinskey
Advertisement
Anthony J. Sinskey, is faculty director, MIT Center for Biomedical Innovation; Professor of Biology, MIT, asinskey@mit.edu.
Articles by Anthony J. Sinskey
Advertisement
Latest Updated Articles
The Impact of SARS-CoV-2 on Biomanufacturing OperationsPublished: August 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
Analytics, Automation, and Quality Driving the Next Era of Drug Development
4
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
5
